FDA Device Intelligence
HomePearl Diagnostics › MycoMEIA Aspergillus Assay 25X Concentrated Wash Solution

MycoMEIA Aspergillus Assay 25X Concentrated Wash Solution

Pearl Diagnostics · Model 25101 · UDI-DI 00860009979567

NOM Prescription
1
510(k) clearances
1
Adverse events
2
Recalls
3
Facilities

Description

The MycoMEIA® Aspergillus Assay (MycoMEIA) is a sandwich enzyme immunoassay (EIA) that detects Aspergillus antigens in urine. The assay uses two mouse monoclonal antibodies that recognize galactofuranose (galf) epitopes. Both monoclonal antibodies are used to coat the wells of the microplate to bind the antigen, and to detect the antigen bound to the sensitized microplate as horseradish-peroxidase conjugates. 25X Concetrated Wash solution is diluted to wash the asssay plates.

Recalls

DateFirmReason
2005-01-25Bio Rad Laboratories, Inc.New instructions to recommend against using samples with visibly high level of blood.
2003-11-06Bio Rad Laboratories, Inc.Potential drug and device interaction with piperacillin/tazobactam (Zosyn) causing positive test result for galactomannan.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.